Letter to the Patent and Trademark Office over Potential Increase in Drug Prices

In the letter, OMI expressed concern over the proposed change that could inflict additional economic hardship on patients and their families and threaten patient health.

StatementsOpen MarketsJuly 9, 20182018, July 2018

Public Comments of the Open Markets Institute Submitted to the Antitrust Division Roundtable Examining the "Consumer Costs of Anticompetitive Regulations"

Read the Open Markets Institute's public comments to the Department of Justice's Antitrust Division for the agency's roundtable on anticompetitive regulations.

StatementsOpen MarketsMay 31, 2018May 2018, 2018

Public Comments of the Open Markets Institute Submitted to the Antitrust Division Roundtable Examining the “Consumer Costs of Anticompetitive Regulations”

Open Markets Institute submitted a comment letter to to the Antitrust Division Roundtable Examining the “Consumer Costs of Anticompetitive Regulations”.

StatementsOpen MarketsMay 30, 20182018, May 2018

Public Comments Submitted by the Open Markets Institute for the Antitrust Division’s Roundtable on Antitrust Consent Decrees

Read the Open Markets Institute's public comments to the Department of Justice's Antitrust Division for the agency's roundtable on antitrust consent decrees.

StatementsOpen MarketsApril 26, 20182018, April 2018

Public Comments Submitted by the Open Markets Institute for the Antitrust Division’s Roundtable on Exemptions and Immunities from the Antitrust Laws

Read the Open Markets Institute’s public comments to the Department of Justice’s Antitrust Division for the agency’s roundtable on exemptions and immunities from the antitrust laws.

StatementsOpen MarketsMarch 14, 2018March 2018, 2018

Monopoly Matters